pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
agilvax PRESS RELEASE ARCHIVE
Aug 18, 2020
AgilVax Progress Triggers $1.2 Million SBIR Fast-Track Grant to Advance Antibody-Based Therapy
Jan 16, 2020
AgilVax Announces Expansion of Series A-1 Financing
Nov 18, 2019
AgilVax to Present Positive Preclinical Data for Monoclonal Antibody Targeting xCT at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference
Nov 7, 2019
AgilVax to Present at the 2019 NYC Oncology Investor Conference
Jul 25, 2019
AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer
May 29, 2019
AgilVax Triggers $2 Million Phase II Fast Track SBIR Grant and Initiates GMP Manufacturing
Jan 9, 2019
Agilvax Elects Dr. David T. Hung, Former Founder and CEO of Medivation, to Its Board of Directors
Nov 13, 2018
Agilvax Appoints Joseph Patti, Ph.D. as Executive Chairman
Aug 7, 2018
Agilvax Awarded $2.3 Million SBIR Fast Track Grant to Advance the Development of AX09 for Triple Negative Breast Cancer
May 15, 2018
Agilvax Closes A1 Financing to Expand Pre-IND Studies for AX09 In Triple Negative Breast Cancer
May 1, 2018
Agilvax Establishes Operations at JLABS @ TMC in Houston
Dec 5, 2017
New Scientific Publication Supports Agilvax’s Novel Immunotherapy Development for Metastatic Breast Cancer
Feb 17, 2015
Agilvax Announces Strategic Collaboration with Humabs BioMed SA to Develop Targeted Vaccines and Immunotherapies
